Ulf Landmesser
Distinguished in Stroke

Ulf Landmesser

Potsdamer Str. 58, 
Berlin, BE, DE 
Distinguished in Stroke
Potsdamer Str. 58, 
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Ulf Landmesser practices in Berlin, Germany. Mr. Landmesser is rated as a Distinguished expert by MediFind in the treatment of Stroke. His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 672 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 69 articles and participated in 3 clinical trials in the study of Stroke.

Gender
Male

Locations

Potsdamer Str. 58, Berlin, BE 10785, Germany
Other Locations
Anna Louisa Karsch Str. 2, Berlin, BE 10178, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
Enrollment Status: Completed
Publish Date: March 26, 2025
Intervention Type: Diagnostic test
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
The REDUCE FMR Trial: Safety and Efficacy of the Carillon Mitral Contour System® in Reducing Functional Mitral Regurgitation (FMR) Associated With Heart Failure
The REDUCE FMR Trial: Safety and Efficacy of the Carillon Mitral Contour System® in Reducing Functional Mitral Regurgitation (FMR) Associated With Heart Failure
Enrollment Status: Completed
Publish Date: August 05, 2024
Intervention Type: Device
Study Phase: Not Applicable
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Enrollment Status: Active_not_recruiting
Publish Date: April 26, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Enrollment Status: Completed
Publish Date: May 19, 2023
Intervention Type: Device
Study Phase: Not Applicable
Phase I-II Randomized Prospective Double-blind Multi-center Trial on the Effects of a Short Course of Oral Everolimus on Infarct Size, Left Ventricular Remodeling and Inflammation in Patients With Acute ST-Elevation Myocardial Infarction
Phase I-II Randomized Prospective Double-blind Multi-center Trial on the Effects of a Short Course of Oral Everolimus on Infarct Size, Left Ventricular Remodeling and Inflammation in Patients With Acute ST-Elevation Myocardial Infarction
Enrollment Status: Completed
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Everolimus
Study Phase: Phase 1/Phase 2
XIENCE 28 Global Study
XIENCE 28 Global Study
Enrollment Status: Completed
Publish Date: March 04, 2021
Intervention Type: Drug, Device
Study Phase: Not Applicable
Evaluation of Cerebral Thrombembolism After TAVR
Evaluation of Cerebral Thrombembolism After TAVR
Enrollment Status: Completed
Publish Date: April 02, 2019
Intervention Type: Other
View 7 Less Clinical Trials

671 Total Publications

Plasma Metabolite N-Formylmethionine Is Associated With Higher Blood Pressure in the Multiethnic HELIUS Cohort and Triggers Vascular Dysfunction.
Plasma Metabolite N-Formylmethionine Is Associated With Higher Blood Pressure in the Multiethnic HELIUS Cohort and Triggers Vascular Dysfunction.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Landmesser's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 23 Advanced Conditions
View All 49 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile